![Stephen Biggar](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen Biggar
Voorzitter bij ACADIA PHARMACEUTICALS INC.
Vermogen: 95 050 $ op 31-05-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Stephen Davis | M | 63 | 13 jaar | |
Sanj Patel | M | 54 | 16 jaar | |
Felix Baker | M | 55 | 24 jaar | |
Gavin MacBeath | M | 54 | 6 jaar | |
Barry Quart | M | 67 | 12 jaar | |
Eben Tessari | M | 42 | 10 jaar | |
Thomas Malley | M | 55 | 18 jaar | |
Michael Megna | M | 53 | 6 jaar | |
Mark Ragosa | M | 50 | 6 jaar | |
Jon Stonehouse | M | 63 | 17 jaar | |
George Abercrombie | M | 69 | 13 jaar | |
Julian Baker | M | 57 | 9 jaar | |
Bob Mischler | M | - | 9 jaar | |
Tracey McCain | F | 56 | 6 jaar | |
Peter Zandstra | M | - |
Notch Therapeutics, Inc.
![]() Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | 6 jaar |
R. Woods | M | 56 | 1 jaar | |
Melissa Manno | F | - | 9 jaar | |
Leiden Dworak | M | - | 2 jaar | |
Rachel Frank | F | - | - | |
Zoran Zdraveski | M | 54 | 3 jaar | |
Albert Kildani | M | - | 1 jaar | |
Elizabeth Garofalo | M | 66 | 4 jaar | |
Brendan Teehan | M | 56 | 6 jaar | |
Gabriela Gruia | M | 67 | 3 jaar | |
Julie Fisher | F | - | 6 jaar | |
Madelyn Zeylikman | F | - | 4 jaar | |
Mark Schneyer | M | 50 | 4 jaar | |
Katina Dorton | F | 66 | 3 jaar | |
Barbara Klencke | M | 66 | 1 jaar | |
William P. Sheridan | M | 69 | 16 jaar | |
Jennifer J. Rhodes | F | 53 | - | |
Don Soland | M | 65 | 9 jaar | |
Kim Popovits | F | 65 | 6 jaar | |
G. Cole | M | 68 | 4 jaar | |
Laura Brege | F | 66 | 16 jaar | |
David Main | M | 59 |
Notch Therapeutics, Inc.
![]() Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | 4 jaar |
Richard Levy | M | 66 | 5 jaar | |
Alane Barnes | F | 58 | 18 jaar | |
Katherine Bishop | M | 58 | 3 jaar | |
Edmund Harrigan | M | 71 | 9 jaar | |
James Daly | M | 62 | 8 jaar | |
Kazenelson Deb | F | - | - | |
Chad Morin | M | - | 4 jaar | |
Rob Ackles | M | - | 10 jaar | |
Kimberly Manhard | F | 64 | - | |
Benir Ruano | M | - | 2 jaar | |
Ray Lockard | M | - | 1 jaar | |
Shrikanta Chattopadhya | M | - | - | |
James Kihara | M | - | 4 jaar | |
Adora Ndu | M | 43 | 2 jaar | |
Ross Moat | M | 43 | 5 jaar | |
Ann Hargraves | F | - | 4 jaar | |
Parag V. Meswani | M | - | 2 jaar | |
Martina Struck | M | - | 6 jaar | |
Heather Savelle | F | - | 3 jaar | |
Jason Amello | M | 55 | - | |
Raf Hofstein | M | 75 |
Notch Therapeutics, Inc.
![]() Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | - |
John Paolini | M | 59 | 8 jaar | |
Timothy Penner | M | 68 |
Notch Therapeutics, Inc.
![]() Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | - |
Justin McCue | M | - | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 95 | 95.96% |
Canada | 4 | 4.04% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Stephen Biggar
- Persoonlijk netwerk